Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thea Pharma is the United States subsidiary of Laboratoires Théa, the leading independent ophthalmology group in Europe. The company specializes in the development and commercialization of innovative products for eye care, covering major therapeutic areas such as glaucoma, dry eye, lid hygiene, and ocular surgery. Thea is particularly known for its pioneering work in preservative-free eye drops, utilizing specialized delivery systems like the ABAK bottle. With a strong focus on research and development, the company continues to expand its portfolio through strategic acquisitions and internal innovation to address unmet needs in the ophthalmic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spectrum Thea Pharmaceuticals.